U.S. markets close in 2 hours 41 minutes
  • S&P 500

    4,227.21
    -5.39 (-0.13%)
     
  • Dow 30

    34,994.01
    +216.25 (+0.62%)
     
  • Nasdaq

    13,549.61
    -202.63 (-1.47%)
     
  • Russell 2000

    2,249.17
    -22.46 (-0.99%)
     
  • Crude Oil

    65.00
    +0.10 (+0.15%)
     
  • Gold

    1,837.40
    +6.10 (+0.33%)
     
  • Silver

    27.53
    +0.05 (+0.19%)
     
  • EUR/USD

    1.2157
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.5930
    +0.0160 (+1.01%)
     
  • GBP/USD

    1.4136
    +0.0146 (+1.04%)
     
  • USD/JPY

    108.8400
    +0.2580 (+0.24%)
     
  • BTC-USD

    57,611.16
    +138.09 (+0.24%)
     
  • CMC Crypto 200

    1,540.38
    -20.92 (-1.34%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,518.34
    +160.52 (+0.55%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLU, SOS and NEPT

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 10, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

BELLUS Health Inc. (NASDAQ:BLU)
Class Period: September 5, 2019 - July 5, 2020
Lead Plaintiff Deadline: May 17, 2021

Throughout the class period, BELLUS Health Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: while BLU-5937's "high selectivity" contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company's Phase 2 trial.

Learn about your recoverable losses in BLU: http://www.kleinstocklaw.com/pslra-1/bellus-health-inc-loss-submission-form?id=15636&from=1

SOS Limited (NYSE:SOS)
Class Period: July 22, 2020 - February 25, 2021
Lead Plaintiff Deadline: June 1, 2021

During the class period, SOS Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (ii) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (iii) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SOS: http://www.kleinstocklaw.com/pslra-1/sos-limited-loss-submission-form?id=15636&from=1

Neptune Wellness Solutions Inc. (NASDAQ:NEPT)
Class Period: July 24, 2019 - February 16, 2021
Lead Plaintiff Deadline: May 17, 2021

The complaint alleges that during the class period Neptune Wellness Solutions Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in NEPT: http://www.kleinstocklaw.com/pslra-1/neptune-wellness-solutions-inc-loss-submission-form?id=15636&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/646235/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-BLU-SOS-and-NEPT